Literature DB >> 22885232

The tyrosine phosphatase STEP constrains amygdala-dependent memory formation and neuroplasticity.

P Olausson1, D V Venkitaramani, T D Moran, M W Salter, J R Taylor, P J Lombroso.   

Abstract

STriatal-Enriched protein tyrosine Phosphatase (STEP; PTPN5) is expressed in brain regions displaying adult neuroplasticity. STEP modulates neurotransmission by dephosphorylating regulatory tyrosine residues on its substrates. In this way, STEP inactivates extracellular-signal-regulated kinase 1/2 (ERK1/2), limiting the duration and spatial distribution of ERK signaling. Two additional substrates, the tyrosine kinase Fyn and the NR2B subunit of the N-methyl-d-aspartic acid receptor, link STEP to glutamate receptor internalization in the synapse. Thus, STEP may act through parallel pathways to oppose the development of experience-dependent synaptic plasticity. We examined the hypothesis that the absence of STEP facilitates amygdala-dependent behavioral and synaptic plasticity (i.e., fear conditioning and long-term potentiation) using STEP-deficient mice (STEP KO). These mice show no detectable expression of STEP in the brain along with increases in Tyr phosphorylation of STEP substrates. Here we demonstrate that STEP KO mice also display augmented fear conditioning as measured by an enhancement in conditioned suppression of instrumental response when a fear-associated conditioned stimulus was presented. Deletion of STEP also increases long-term potentiation and ERK phosphorylation in the lateral amygdala. The current experiments demonstrate that deletion of STEP can enhance experience-induced neuroplasticity and memory formation and identifies STEP as a target for pharmacological treatment aimed at improving the formation of long-term memories.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885232      PMCID: PMC3725644          DOI: 10.1016/j.neuroscience.2012.07.069

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  42 in total

1.  Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning.

Authors:  G E Schafe; C M Atkins; M W Swank; E P Bauer; J D Sweatt; J E LeDoux
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation.

Authors:  Kenneth A Pelkey; Rand Askalan; Surojit Paul; Lorraine V Kalia; Tri Hung Nguyen; Graham M Pitcher; Michael W Salter; Paul J Lombroso
Journal:  Neuron       Date:  2002-03-28       Impact factor: 17.173

3.  Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.

Authors:  S M Goebel-Goody; E D Wilson-Wallis; S Royston; S M Tagliatela; J R Naegele; P J Lombroso
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

4.  Reduced levels of the tyrosine phosphatase STEP block β amyloid-mediated GluA1/GluA2 receptor internalization.

Authors:  Yongfang Zhang; Pradeep Kurup; Jian Xu; George M Anderson; Paul Greengard; Angus C Nairn; Paul J Lombroso
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

5.  Lesions of periaqueductal gray dissociate-conditioned freezing from conditioned suppression behavior in rats.

Authors:  P Amorapanth; K Nader; J E LeDoux
Journal:  Learn Mem       Date:  1999 Sep-Oct       Impact factor: 2.460

6.  Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420.

Authors:  Tri-Hung Nguyen; Jian Liu; Paul J Lombroso
Journal:  J Biol Chem       Date:  2002-04-30       Impact factor: 5.157

Review 7.  The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory.

Authors:  J D Sweatt
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

8.  Striatal-enriched protein-tyrosine phosphatase (STEP) regulates Pyk2 kinase activity.

Authors:  Jian Xu; Pradeep Kurup; Jason A Bartos; Tommaso Patriarchi; Johannes W Hell; Paul J Lombroso
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

Review 9.  Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders.

Authors:  Susan M Goebel-Goody; Matthew Baum; Constantinos D Paspalas; Stephanie M Fernandez; Niki C Carty; Pradeep Kurup; Paul J Lombroso
Journal:  Pharmacol Rev       Date:  2011-11-16       Impact factor: 25.468

10.  The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications.

Authors:  N C Carty; J Xu; P Kurup; J Brouillette; S M Goebel-Goody; D R Austin; P Yuan; G Chen; P R Correa; V Haroutunian; C Pittenger; P J Lombroso
Journal:  Transl Psychiatry       Date:  2012-07-10       Impact factor: 6.222

View more
  14 in total

1.  Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels.

Authors:  Jian Xu; Pradeep Kurup; Garikoitz Azkona; Tyler D Baguley; Ana Saavedra; Angus C Nairn; Jonathan A Ellman; Esther Pérez-Navarro; Paul J Lombroso
Journal:  J Neurochem       Date:  2015-09-17       Impact factor: 5.372

2.  Striatal-enriched protein tyrosine phosphatase-STEPs toward understanding chronic stress-induced activation of corticotrophin releasing factor neurons in the rat bed nucleus of the stria terminalis.

Authors:  Joanna Dabrowska; Rimi Hazra; Ji-Dong Guo; Chenchen Li; Sarah Dewitt; Jian Xu; Paul J Lombroso; Donald G Rainnie
Journal:  Biol Psychiatry       Date:  2013-09-05       Impact factor: 13.382

3.  STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.

Authors:  Pradeep K Kurup; Jian Xu; Rita Alexandra Videira; Chimezie Ononenyi; Graça Baltazar; Paul J Lombroso; Angus C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

4.  Proteolytic Degradation of Hippocampal STEP61 in LTP and Learning.

Authors:  Ana Saavedra; Jesús J Ballesteros; Shiraz Tyebji; Sara Martínez-Torres; Gloria Blázquez; Rosa López-Hidalgo; Garikoitz Azkona; Jordi Alberch; Eduardo D Martín; Esther Pérez-Navarro
Journal:  Mol Neurobiol       Date:  2018-06-12       Impact factor: 5.590

5.  Disruption of Striatal-Enriched Protein Tyrosine Phosphatase Signaling Might Contribute to Memory Impairment in a Mouse Model of Sepsis-Associated Encephalopathy.

Authors:  Man-Man Zong; Hong-Mei Yuan; Xue He; Zhi-Qiang Zhou; Xiao-Dong Qiu; Jian-Jun Yang; Mu-Huo Ji
Journal:  Neurochem Res       Date:  2019-11-06       Impact factor: 3.996

6.  Altered Intracellular Calcium Homeostasis Underlying Enhanced Glutamatergic Transmission in Striatal-Enriched Tyrosine Phosphatase (STEP) Knockout Mice.

Authors:  Federica Bosco; Pierluigi Valente; Marco Milanese; Alessandra Piccini; Mirko Messa; Giambattista Bonanno; Paul Lombroso; Pietro Baldelli; Fabio Benfenati; Silvia Giovedì
Journal:  Mol Neurobiol       Date:  2018-03-05       Impact factor: 5.590

Review 7.  Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders.

Authors:  Takatoshi Karasawa; Paul J Lombroso
Journal:  Neurosci Res       Date:  2014-09-10       Impact factor: 3.304

8.  Striatal-enriched protein tyrosine phosphatase controls responses to aversive stimuli: implication for ethanol drinking.

Authors:  Rémi Legastelois; Emmanuel Darcq; Scott A Wegner; Paul J Lombroso; Dorit Ron
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

9.  Association of Extracellular Signal-Regulated Kinase Genes With Myopia: A Longitudinal Study of Chinese Children.

Authors:  Haishao Xiao; Shudan Lin; Dandan Jiang; Yaoyao Lin; Linjie Liu; Qiqi Zhang; Juan He; Yanyan Chen
Journal:  Front Genet       Date:  2021-05-27       Impact factor: 4.599

10.  Regulation of tyrosine phosphatase STEP61 by protein kinase A during motor skill learning in mice.

Authors:  Laure Chagniel; Yan Bergeron; Geneviève Bureau; Guy Massicotte; Michel Cyr
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.